CervoMed Inc. (CRVO) annual cash flow statement — 23-year operating, investing & financing history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'99 | Dec'98 |
|---|
| Cash from Operations | -27.57M | -23.45M | -16.53M | -7.45M | -2.57M | -14.5M | -13.55M | -9.86M | -10.77M | -12.33M | -10.77M | -5.19M | -9.03M | -1.18M | -4.31M | -12.02M | -1.98M | -1.06M | -505.95K | 0 | 0 | -75K | -8.35M | -7.1M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | -1652.96% | -1150.87% | -2107.8% | -4929.52% | - | -1258.93% | - | - | - | -30.98% | -25.44% |
| Operating CF Growth % | -316.65% | -41.86% | -121.89% | -189.57% | 82.26% | -7% | -37.47% | 8.49% | 12.65% | -14.52% | -107.67% | 42.58% | -662.27% | 72.52% | 64.15% | -506.95% | -87.42% | -108.93% | - | - | 100% | 99.1% | -17.55% | - |
| Net Income | -30.04M | -26.97M | -16.29M | -2.17M | -5.8M | -24.1M | -14.19M | -11.8M | -18.37M | -1.36M | -18.04M | -6.72M | -14.35M | -2.46M | -6.85M | -23.03M | -8.41M | -3.4M | -2.09M | -60.76K | -48.1K | 0 | -8.06M | 200K |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 | 93.42K | 103.17K | 97.92K | 110.37K | 67.98K | 25.34K | 8.27K | 566.26K | 118.31K | 164.04K | 119.81K | 49.67K | 47.2K | 55.85K | 0 | 0 | 0 | -386.99K | -200K |
| Stock-Based Compensation | 846.21K | 1.45M | 1.41M | 407.63K | 333.83K | 897.26K | 736.12K | 0 | 0 | 0 | 0 | 594.17K | 1.61M | 2.23M | 3.77M | 0 | 1.36M | 158.15K | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | -443.89K | -1.68M | 332.88K | -437.29K | -1.06M | -364.8K | 0 | -2.82M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -353.36K | -854.08K | -1.21M | -5.42M | 2.52M | 8.69M | 0 | 515.38K | 8.7M | -5.85M | 6.35M | 313.61K | 8.79M | -3.3M | -5M | 10.82M | 4.29M | 1.8M | 1.53M | 0 | 0 | -94.86K | 781.25K | 400K |
| Working Capital Changes | 1.97M | 2.92M | -440.66K | -261.36K | 379.94K | 356.37K | 1.47M | 994.44K | -276.94K | -2.33M | 1.31M | 617.85K | -2.82M | 2.22M | 3.6M | 64.14K | 728.29K | 336.28K | -1.05K | 60.76K | 48.1K | 19.86K | -679.91K | -7.5M |
| Change in Receivables | 629.64K | 1.83M | -1.34M | -915.4K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 69.93K | 71.95K | 0 | 0 | 10.16K | -10.16K | 0 | 0 | 0 | 2.42M | -3.7M |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10.16K | 0 | 0 | 0 | 0 | -5.61M | -5.3M |
| Change in Payables | 783.7K | -67.32K | 848.97K | 565.17K | 79.15K | 605.37K | 950.6K | 567.67K | -275.83K | -1.66M | 0 | 647.58K | -3.8M | 1.6M | 414.36K | -114.24K | 518.31K | -8.97K | 11.19K | 0 | 0 | 0 | 809.29K | 1M |
| Cash from Investing | 20.41M | 18.1M | -28.66M | 0 | 0 | 4K | 0 | 0 | 0 | -447.82K | 8.5M | 2.46M | -50.91K | 0 | 0 | -985.89K | -1.38M | -213.12K | 0 | 0 | 0 | 0 | -944.06K | -600K |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -447.82K | -2.33K | -40.29K | -50.91K | 0 | 0 | -125K | -13.64K | -1.12K | 0 | 0 | 0 | 0 | -919.89K | -600K |
| CapEx % of Revenue | 0% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 21.91% | 33.93% | - | - | - | - | - | 3.41% | 2.15% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 4K | 0 | 0 | 0 | 0 | 8.5M | -250K | 0 | 0 | 0 | -860.89K | 0 | -212K | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 7.58M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.75M | 0 | 0 | 0 | 0 | -1.37M | 0 | 0 | 0 | 0 | 0 | -24.17K | 0 |
| Cash from Financing | 4.6M | 4.59M | 46.4M | 11.15M | 0 | 33.3M | 17.89M | 16.04M | 9.87M | 20.12M | 1.83M | 2.39M | 30.71M | 1.13M | 4.52M | 13.11M | 3.37M | 1.27M | 506.55K | 0 | 0 | 75K | 9.32M | 7.6M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 6M | 0 | 0 | -550K | -1.88M | 1.88M | 2.4M | -1.14M | 700K | 3.51M | -223.79K | 429.85K | -44.24K | -118.45K | 0 | 0 | 75K | 0 | 0 |
| Equity Issued (Net) | 4.6M | 4.59M | 46.4M | 810K | 0 | 31.09M | 10.83M | 12.32M | 10.85M | 22.13M | -54.35K | 0 | 31.85M | 427.5K | 1.01M | 13.4M | 2.94M | 1.29M | 625K | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 10.34M | 0 | -3.8M | 7.06M | 3.73M | -428.54K | -125.98K | 0 | -15.31K | 0 | 0 | 0 | -62.8K | 0 | 19.63K | 0 | 0 | 0 | 0 | 9.32M | 7.6M |
| Net Change in Cash | -2.56M | -764.03K | 1.21M | 3.7M | -33.22M | 18.8M | 4.34M | 6.19M | -905.3K | 7.34M | -444.34K | -339.33K | 21.63M | -57.13K | 213.64K | 98.45K | 0 | -800 | 604 | 0 | 0 | 0 | 25.3K | -100K |
| Free Cash Flow | -27.57M | -23.45M | -16.53M | -7.45M | -2.57M | -14.5M | -13.55M | -9.86M | -10.77M | -12.78M | -10.77M | -5.23M | -9.08M | -1.18M | -4.31M | -12.15M | -1.99M | -1.06M | -505.95K | 0 | 0 | -75K | -9.27M | -7.7M |
| FCF Margin % | -8548.23% | - | - | - | - | - | - | - | - | - | - | - | - | -1652.96% | -1150.87% | -2129.71% | -4963.45% | - | -1258.93% | - | - | - | -34.39% | -27.59% |
| FCF Growth % | -45.11% | -41.86% | -121.89% | -189.57% | 82.26% | -7% | -37.47% | 8.49% | 15.71% | -18.66% | -106.11% | 42.46% | -666.57% | 72.52% | 64.52% | -509.07% | -88.51% | -109.15% | - | - | 100% | 99.19% | -20.34% | - |
| FCF per Share | -2.98 | -2.59 | -2.05 | -2.80 | -4.97 | -11.14 | -18.88 | -110.25 | -249.20 | -1127.20 | -1184.23 | -22438.72 | -7144.80 | -5035.54 | -54563.08 | -155762.54 | -35620.75 | -20634.44 | -10325.51 | - | - | -712047.85 | - | - |
| FCF Conversion (FCF/Net Income) | 0.92x | 0.87x | 1.01x | 3.43x | 0.44x | 0.60x | 0.96x | 0.84x | 0.59x | 9.03x | 0.60x | 0.77x | 0.63x | 0.48x | 0.63x | 0.53x | 0.24x | 0.31x | 0.24x | - | - | 0.79x | 1.04x | -35.50x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -677.25K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying CRVO stock.
CervoMed Inc. (CRVO) generated $-23.4M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.
CervoMed Inc. (CRVO) reported negative free cash flow of $23.4M in 2025, indicating capital requirements exceeded cash from operations.
CervoMed Inc. (CRVO) spent $0.0M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.